tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:ZEGA Stock Latest News

Trump to impose 100% tariff on drugs unless manufacturer building U.S. plant
The FlyTrump to impose 100% tariff on drugs unless manufacturer building U.S. plant
4h ago
AZN
BMY
Monopar Therapeutics price target raised to $104 from $87 at BTIG
PremiumThe Fly
Monopar Therapeutics price target raised to $104 from $87 at BTIG
1d ago
AZN
MNPR
AstraZeneca, Daiichi Sankyo Enhertu plus pertuzumab sBLA granted priority review
PremiumThe Fly
AstraZeneca, Daiichi Sankyo Enhertu plus pertuzumab sBLA granted priority review
2d ago
AZN
Burning Rock announces OncoGuide OncoScreen Plus CDx System approval in Japan
PremiumThe Fly
Burning Rock announces OncoGuide OncoScreen Plus CDx System approval in Japan
2d ago
AZN
BNR
Sophia Genetics expands collaboration with AstraZeneca
PremiumThe Fly
Sophia Genetics expands collaboration with AstraZeneca
4d ago
AZN
SOPH
AstraZeneca, Amgen’s Tezspire recommended for approval in EU
PremiumThe FlyAstraZeneca, Amgen’s Tezspire recommended for approval in EU
4d ago
AZN
AMGN
AstraZeneca’s Koselugo has been recommended for approval in EU
Premium
The Fly
AstraZeneca’s Koselugo has been recommended for approval in EU
4d ago
AZN
AstraZeneca updates Airsupra U.S. prescribing information
Premium
The Fly
AstraZeneca updates Airsupra U.S. prescribing information
8d ago
AZN
AstraZeneca reports Saphnelo demonstrates reduction in disease activity
PremiumThe Fly
AstraZeneca reports Saphnelo demonstrates reduction in disease activity
9d ago
AZN
Trump Weekly: Trump signs pharma order, FTC opens inquiry into AI chatbots
PremiumThe Fly
Trump Weekly: Trump signs pharma order, FTC opens inquiry into AI chatbots
13d ago
DV
ES
AstraZeneca pauses planned $270M investment in Britain, Reuters reports
PremiumThe Fly
AstraZeneca pauses planned $270M investment in Britain, Reuters reports
14d ago
AZN
MRK
Trump officials to link COVID shots to child deaths, WaPo reports
PremiumThe Fly
Trump officials to link COVID shots to child deaths, WaPo reports
14d ago
AZN
PFE
AstraZeneca announces EMA validation for Enhertu marketing authorization
PremiumThe FlyAstraZeneca announces EMA validation for Enhertu marketing authorization
15d ago
AZN
Advertising, drugmaker stocks in spotlight as Trump moves to regulate pharma ads
Premium
The Fly
Advertising, drugmaker stocks in spotlight as Trump moves to regulate pharma ads
16d ago
DV
AZN
Omnicom, WPP under pressure after Trump moves to regulate pharma ads
Premium
The Fly
Omnicom, WPP under pressure after Trump moves to regulate pharma ads
16d ago
AZN
BMY
Trump Trade: U.S. President signs new pharma order
PremiumThe Fly
Trump Trade: U.S. President signs new pharma order
16d ago
DV
AZN
FDA expands approval of AstraZeneca’s Koselugo
PremiumThe Fly
FDA expands approval of AstraZeneca’s Koselugo
16d ago
AZN
Trump signs memorandum mandating pharma ads give more info on risks
PremiumThe Fly
Trump signs memorandum mandating pharma ads give more info on risks
16d ago
AZN
BMY
AstraZeneca announces results from FLAURA2 Phase III trial of TAGRISSO
PremiumThe Fly
AstraZeneca announces results from FLAURA2 Phase III trial of TAGRISSO
19d ago
AZN
AstraZeneca call volume above normal and directionally bullish
PremiumThe FlyAstraZeneca call volume above normal and directionally bullish
22d ago
AZN
AstraZeneca’s Promising Pipeline and Valuation: A Compelling Investment Opportunity
Premium
Ratings
AstraZeneca’s Promising Pipeline and Valuation: A Compelling Investment Opportunity
22d ago
AZN
AstraZeneca’s Promising Outlook: Buy Rating Backed by Baxdrostat’s Clinical Success and Strategic Advantages
Premium
Ratings
AstraZeneca’s Promising Outlook: Buy Rating Backed by Baxdrostat’s Clinical Success and Strategic Advantages
22d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >